HIV Diagnostics Market Size to Hit USD 2.24 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on HIV Diagnostics Market

5.1. COVID-19 Landscape: HIV Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global HIV Diagnostics Market, By Product Type

8.1. HIV Diagnostics Market Revenue and Volume Forecast, by Product Type

8.1.1. Tests Kits

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Instruments

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Software

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global HIV Diagnostics Market, By Test Type

9.1. HIV Diagnostics Market Revenue and Volume Forecast, by Test Type

9.1.1. Antibody Tests

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Antigen Tests

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Nucleic Acid Tests

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global HIV Diagnostics Market, By Technology

10.1. HIV Diagnostics Market Revenue and Volume Forecast, by Technology

10.1.1. ELISA

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Rapid Testing

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Polymerase Chain Reaction

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global HIV Diagnostics Market, By End User

11.1. HIV Diagnostics Market Revenue and Volume Forecast, by End User

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Diagnostic Laboratories

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Home Care Settings

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global HIV Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by Test Type

12.1.3. Market Revenue and Volume Forecast, by Technology

12.1.4. Market Revenue and Volume Forecast, by End User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by Test Type

12.1.5.3. Market Revenue and Volume Forecast, by Technology

12.1.5.4. Market Revenue and Volume Forecast, by End User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by Test Type

12.1.6.3. Market Revenue and Volume Forecast, by Technology

12.1.6.4. Market Revenue and Volume Forecast, by End User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by Test Type

12.2.3. Market Revenue and Volume Forecast, by Technology

12.2.4. Market Revenue and Volume Forecast, by End User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by Test Type

12.2.5.3. Market Revenue and Volume Forecast, by Technology

12.2.5.4. Market Revenue and Volume Forecast, by End User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by Test Type

12.2.6.3. Market Revenue and Volume Forecast, by Technology

12.2.6.4. Market Revenue and Volume Forecast, by End User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by Test Type

12.2.7.3. Market Revenue and Volume Forecast, by Technology

12.2.7.4. Market Revenue and Volume Forecast, by End User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by Test Type

12.2.8.3. Market Revenue and Volume Forecast, by Technology

12.2.8.4. Market Revenue and Volume Forecast, by End User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by Test Type

12.3.3. Market Revenue and Volume Forecast, by Technology

12.3.4. Market Revenue and Volume Forecast, by End User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by Test Type

12.3.5.3. Market Revenue and Volume Forecast, by Technology

12.3.5.4. Market Revenue and Volume Forecast, by End User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by Test Type

12.3.6.3. Market Revenue and Volume Forecast, by Technology

12.3.6.4. Market Revenue and Volume Forecast, by End User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by Test Type

12.3.7.3. Market Revenue and Volume Forecast, by Technology

12.3.7.4. Market Revenue and Volume Forecast, by End User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by Test Type

12.3.8.3. Market Revenue and Volume Forecast, by Technology

12.3.8.4. Market Revenue and Volume Forecast, by End User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by Test Type

12.4.3. Market Revenue and Volume Forecast, by Technology

12.4.4. Market Revenue and Volume Forecast, by End User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by Test Type

12.4.5.3. Market Revenue and Volume Forecast, by Technology

12.4.5.4. Market Revenue and Volume Forecast, by End User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by Test Type

12.4.6.3. Market Revenue and Volume Forecast, by Technology

12.4.6.4. Market Revenue and Volume Forecast, by End User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by Test Type

12.4.7.3. Market Revenue and Volume Forecast, by Technology

12.4.7.4. Market Revenue and Volume Forecast, by End User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by Test Type

12.4.8.3. Market Revenue and Volume Forecast, by Technology

12.4.8.4. Market Revenue and Volume Forecast, by End User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by Test Type

12.5.3. Market Revenue and Volume Forecast, by Technology

12.5.4. Market Revenue and Volume Forecast, by End User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by Test Type

12.5.5.3. Market Revenue and Volume Forecast, by Technology

12.5.5.4. Market Revenue and Volume Forecast, by End User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by Test Type

12.5.6.3. Market Revenue and Volume Forecast, by Technology

12.5.6.4. Market Revenue and Volume Forecast, by End User

Chapter 13. Company Profiles

13.1. Alere Inc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProduct Typeance

13.1.4. Recent Initiatives

13.2. Abbott

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProduct Typeance

13.2.4. Recent Initiatives

13.3. Bristol-Myers Squibb Company

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProduct Typeance

13.3.4. Recent Initiatives

13.4. Janssen Global Services, LLC

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProduct Typeance

13.4.4. Recent Initiatives

13.5. Gilead Sciences, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProduct Typeance

13.5.4. Recent Initiatives

13.6. Merck & Co. Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProduct Typeance

13.6.4. Recent Initiatives

13.7. VIIV Healthcare

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProduct Typeance

13.7.4. Recent Initiatives

13.8. BD

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProduct Typeance

13.8.4. Recent Initiatives

13.9. Beckman Coulter, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProduct Typeance

13.9.4. Recent Initiatives

13.10. Sysmex Europe SE

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProduct Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The HIV diagnostics market size is expected to increase from USD 1.34 billion in 2025 to USD 2.24 billion by 2035.

Answer : The HIV diagnostics market is expected to grow at a compound annual growth rate (CAGR) of around 5.26% from 2026 to 2035.

Answer : The major players in the HIV diagnostics market include Alere Inc,Abbott,Bristol-Myers Squibb Company,Janssen Global Services,LLC,Gilead Sciences, Inc.,Merck & Co.Inc.,VIIV Healthcare,BD, Beckman Coulter,Inc.,Sysmex Europe SE,Apogee Flow Systems,Point Care,Siemens Healthcare GmbH,QIAGEN,Zyomtronix,Inc.,Mylan N.V.,F.Hoffmann-La Roche Ltd

Answer : The driving factors of the HIV diagnostics market are the surging awareness of AIDS among people, along with rapid investments in healthcare infrastructure.

Answer : North America region will lead the global HIV diagnostics market during the forecast period 2026 to 2035.